Cyanvac
0 followers
‌
Cyanvac develops vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.
Industries
+1
Headquarters
Links
Org chart
Fred C. Davison
Chief Executive Officer
Fred C. Davison
Collapse
Gary Titus
Chief Financial Officer
Hong Jin
Chief Scientific Officer
Marinka Tellier
Chief Regulatory Officer
Samuel Wu
Chief Business Officer
